Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical AS101 for FAGA in Menopause Women
NCT00418249Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AS-101 in androgenetic alopecia (AGA), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
AS-101
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT00418249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418249.